erlotinib

E2190162 UNEXPLORED

Erlotinib is a small-molecule tyrosine kinase inhibitor used primarily to treat certain non-small cell lung cancers and pancreatic cancers driven by aberrant EGFR signaling.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
erlotinib canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

EGFR → targetOfDrug → erlotinib ⓘ